Fibroid embolization proves primacy in two trial results

Article

Two major studies have concluded that uterine artery embolization is as good as or better than hysterectomy or myomectomy for treatment of uterine fibroids.

The multicenter Embolization versus Hysterectomy (EMMY) trial enrolled 177 women with uterine fibroids who were randomized to undergo UAE or hysterectomy. All UAE patients showed significant improvement six months after treatment, while a smaller proportion of hysterectomy patients did. UAE patients also spent less time in the hospital than their counterparts. Another study, the Fibroid Registry for Outcomes Data (FIBROID), showed that 90% of the participating women avoided hysterectomy or myomectomy by undergoing UAE. About 85% reported improved symptoms and quality of life. The registry included three-year data on 1278 patients from 26 U.S. sites.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.